Míriam Tarrado-Castellarnau

6PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersMolecular targetsCrop and pasture biomass and bioproductsMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 22, 2025
Glutaminase as a metabolic target of choice to counter acquired resistance to Palbociclib by colorectal cancer cells.

Míriam Tarrado-Castellarnau, Carles Foguet, Josep Tarragó-Celada

|Sep 28, 2021
Glutamine Modulates Expression and Function of Glucose 6-Phosphate Dehydrogenase via NRF2 in Colon Cancer Cells.

Ibrahim H Polat, Míriam Tarrado-Castellarnau, Adrian Benito

|Jul 23, 2021
Integrating systemic and molecular levels to infer key drivers sustaining metabolic adaptations.

Pedro de Atauri, Míriam Tarrado-Castellarnau, Josep Tarragó-Celada

|Jan 27, 2021
Cysteine and Folate Metabolism Are Targetable Vulnerabilities of Metastatic Colorectal Cancer.

Josep Tarragó-Celada, Carles Foguet, Míriam Tarrado-Castellarnau

|Jan 27, 2021
Oxidative Pentose Phosphate Pathway Enzyme 6-Phosphogluconate Dehydrogenase Plays a Key Role in Breast Cancer Metabolism.

Ibrahim H Polat, Míriam Tarrado-Castellarnau, Rohit Bharat

Pageof 1